Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wang, Hongjun ^a   Zhao, Yan ^a   Zhang, Chuanbao ^b   Li, Mingyang ^b   Jiang, Chuanlu ^a   Li, Yongli ^a  

^a Medical University   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; MESSENGER RNA; RAB27A PROTEIN; RAB PROTEIN; RAB27A PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN SURGERY; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; CHINA; EPIDEMIOLOGY; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MICROARRAY ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS;

BIOMARKERS, TUMOR; CHINA; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MICROARRAY ANALYSIS; PROGNOSIS; RAB GTP-BINDING PROTEINS;

EID: 84896361393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089782     Document Type: Article

References (23)

1. Yan W, Zhang W, You G, Zhang J, Han L, et al. (2012) Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol 14: 1432-1440.
2. Bao Z, Zhang C, Yan W, Liu Y, Li M, et al. (2013) BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas. J Transl Med 11: 100.
3. Recchi C, Seabra MC (2012) Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochem Soc Trans 40: 1398-1403.
4. Wang JS, Wang FB, Zhang QG, Shen ZZ, Shao ZM (2008) Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol Cancer Res 6: 372-382.
5. Dong WW, Mou Q, Chen J, Cui JT, Li WM, et al. (2012) Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J Gastroenterol 18: 1806-1813.
6. Uchino K, Takeshita F, Takahashi RU, Kosaka N, Fujiwara K, et al. (2013) Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol Ther 21: 610-619.
7. Wu X, Hu A, Zhang M, Chen Z (2013) Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell. Tumour Biol.
8. Liu Y, Zhou Y, Zhu K (2012) Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One 7: e45910.
9. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
10. Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, et al. (2009) Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 69: 9065-9072.
11. Wang H, Wang Y, Jiang C (2013) Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype. Int J Oncol 42: 1716-1724.
12. Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 14: 7.
13. R (2012) Core Team: A language and enviroment for statistical computing. Vienna, Austria: R Foundation for Statistical Conputing.
14. Senft C, Priester M, Polacin M, Schroder K, Seifert V, et al. (2011) Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101: 393-403.
15. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996. (Pubitemid 40349501)
16. Wang Y, Chen L, Bao Z, Li S, You G, et al. (2011) Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways. Oncol Rep 26: 1173-1180.
17. He H, Dai F, Yu L, She X, Zhao Y, et al. (2002) Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expr 10: 231-242. (Pubitemid 35315385)
18. Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, et al. (2005) Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92: 1915-1921. (Pubitemid 40826141)
19. Culine S, Honore N, Closson V, Droz JP, Extra JM, et al. (1994) A small GTP-binding protein is frequently overexpressed in peripheral blood mononuclear cells from patients with solid tumours. Eur J Cancer 30A: 670-674. (Pubitemid 24164257)
20. Yao R, Wang Y, Lubet RA, You M (2002) Differentially expressed genes associated with mouse lung tumor progression. Oncogene 21: 5814-5821. (Pubitemid 35333016)
21. Overmeyer JH, Young AM, Bhanot H, Maltese WA (2011) A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells. Mol Cancer 10: 69.
22. Catz SD (2008) Characterization of Rab27a and JFC1 as constituents of the secretory machinery of prostate-specific antigen in prostate carcinoma cells. Methods Enzymol 438: 25-40.
23. Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, et al. (2012) Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 72: 4920-4930.